Foresite Capital Management VI
Latest statistics and disclosures from Foresite Capital Management VI's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CGON, RAPT, ALMS, CNTA, VSTM, and represent 74.03% of Foresite Capital Management VI's stock portfolio.
- Added to shares of these 5 stocks: NTRA (+$15M), AGIO (+$14M), Atai Life Sciences Nv (+$11M), VSTM, CNTA.
- Started 3 new stock positions in AGIO, NTRA, Atai Life Sciences Nv.
- Reduced shares in these 4 stocks: AKRO (-$12M), CRVS, RNA, CASI.
- Sold out of its positions in AKRO, RNA, CASI.
- Foresite Capital Management VI was a net buyer of stock by $29M.
- Foresite Capital Management VI has $331M in assets under management (AUM), dropping by 27.80%.
- Central Index Key (CIK): 0002013341
Tip: Access up to 7 years of quarterly data
Positions held by Foresite Capital Management VI consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Foresite Capital Management VI
Foresite Capital Management VI holds 12 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cg Oncology (CGON) | 27.9 | $92M | 2.2M | 41.52 |
|
|
| Rapt Therapeutics (RAPT) | 16.0 | $53M | 1.6M | 33.87 |
|
|
| Alumis (ALMS) | 12.5 | $42M | 4.2M | 9.76 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 10.3 | $34M | +3% | 1.4M | 25.01 |
|
| Verastem (VSTM) | 7.3 | $24M | +19% | 3.1M | 7.72 |
|
| Denali Therapeutics (DNLI) | 5.0 | $17M | 1.0M | 16.51 |
|
|
| Natera (NTRA) | 4.7 | $15M | NEW | 67k | 229.09 |
|
| Agios Pharmaceuticals (AGIO) | 4.4 | $14M | NEW | 530k | 27.22 |
|
| Kymera Therapeutics (KYMR) | 3.4 | $11M | 146k | 77.81 |
|
|
| Atai Beckley SHS | 3.4 | $11M | NEW | 2.8M | 4.09 |
|
| Corvus Pharmaceuticals (CRVS) | 3.2 | $11M | -20% | 1.4M | 7.70 |
|
| Hinge Health Cl A (HNGE) | 1.9 | $6.3M | 135k | 46.45 |
|
Past Filings by Foresite Capital Management VI
SEC 13F filings are viewable for Foresite Capital Management VI going back to 2025
- Foresite Capital Management VI 2025 Q4 filed Feb. 17, 2026
- Foresite Capital Management VI 2025 Q3 filed Nov. 14, 2025
- Foresite Capital Management VI 2025 Q2 filed Aug. 12, 2025